Method: In this study, a modification of the Vauzelle method of wake up test was employed. A relatively new analgesic drug, nalbuphine Hydrochloride, was used in a balanced anesthetic technique, in searching for a better methid of anesthesia that will allow awakening and spinal cord monitoring during surgey. Results: All patients were sucessfully awakened and were able to move their feet on command in 2 to 5 minutes (mean = 3.3 min. ) after the surgeon requested for the test. All patients were breathing spontaneously after the muscle relaxant was partially reversed. None required naloxone for the procedure. No complications related to the test were noted, such as self- extubation nor excessive struggling that may jeopardize the rod fixation. There were no neurological complications in this series. Conclusion: The result of our study in 5 patients indicate that balanced anesthesia with nalbuphine hydrochloride can be recommended for intraoperative awakening to monitor spinal cord function during surgery. The rapid return of wakefulness effective analgesia, reduced blood loss, stable cardiovascular system and minimal respiratory depression, make it one of the anesthetics of choice for the special procedure.
Human ; SCOLIOSIS ; NALBUPHINE ; ANESTHESIA

Nalbuphine, a mixed agonist-antagonist type opioid, can precipitate abstinence syndrome in opioid-dependent patients especially in large doses. We can prevent this syndrome by avoiding the injection of agonist-antagonist type opioid to the patient who already has used opioid for a long time, and the method of relatively small dose increments in its use. We experienced a case of opioid withdrawal symptom in chronically morphine-administered patient via epidural catheter after using intramuscular nalbuphine for analgesia. The symptom was promptly relieved by intravascular morphine injection without any problems.
Analgesia ; Catheters ; Humans ; Morphine ; Nalbuphine* ; Substance Withdrawal Syndrome*

BACKGROUND: The effectiveness of preemptive analgesia is still controversial. This study was designed to compare the effects of nalbuphine used in the pre-anesthesia period and after surgery for pain control when performing adenoidectomy or tonsillectomy in children. METHODS: Two hundreds four patients (aged 3 to 12 years) were randomly allocated into two groups: the preemptive group (group P, n = 98) and the intraoperative group (group I, n = 106). Nalbuphine 0.1 mg/kg was administered into the patients before induction of anesthesia in group P and it was injected at least 10 minutes after the beginning of surgery in group I. The anesthesia was performed in the conventional fashion. The pain score, the sedation score and the agitation score were checked and recorded in the postanesthetic room (PAR) at arrival (0), at 15 minutes and at 30 minutes. RESULTS: The pain scores for PAR 0, 15 and 30 minutes were significantly lower in group I than those in group P. The other sedation scores or agitation scores were similar in both groups. CONCLUSIONS: Nalbuphine used during the pre-anesthetic period was less effective than that used in the intraoperative period for pain control when performing adenoidectomy or tonsillectomy in children.
Adenoidectomy ; Analgesia ; Anesthesia ; Child ; Dihydroergotamine ; Humans ; Intraoperative Period ; Nalbuphine ; Tonsillectomy

This study was performed to compare the effects of epidural morphine and nalbuphine with general anesthesia for relief of pain after abdominal surgery. Patients were devided into three groups like Group I(General anesthesia), II(Epidural mor- phine) and III(Epidural nalbuphine). Pain score, gas passing and ambulation time were checked in all groups respectively. And side effects inclduing urinary retention and respiratory changes were evaluated too. The results were as follow. 1) The effects of epidural morphine and nalbuphine on pain relief were better than general anesthesia. And the effect of epidural morphine was superior to epidural nalbuphine too. 2) Ambulation time was the shortest in epidural morphine group. 3) Urinary retention, gas pasing time and respiratory changes were similar in a11 groups.
Anesthesia, General ; Humans ; Morphine* ; Nalbuphine* ; Urinary Retention ; Walking

PURPOSE: The PerFix(R) plug is preformed as a Marlex mesh hernia plug, and consists of a fluted outer layer combined with an inner arrangement of eight mesh "petals." In contrast to hand-rolled hernia plugs, which can collapse on themselves, the PerFix(R) plug's petals maintain the device's open conelike shape. The fluted design allows the plug to more readily conform to the configuration of any indirect or direct defect. METHODS: Bewteen January 1996 and April 2000 126 conventional herniorrhaphies (C group: Bassini: 23, Shouldice: 15, McVay: 5, Lichtenstein: 83) were performed, and between May 2000 and April 2002, 124 PerFix(R) plug repairs (P group) were completed. The operation times, lengths of hospital stay, visual analogue pain scales, time of analgesics use, and complication and recurrence rates were compared between these two groups. RESULTS: The operation times and lengths of hospital stay for groups C and P were 56.4 vs. 31.1 minutes and 4.4 vs. 2.8 days, respectively, so where significantly shorter in the P group (P<0.01). The times of use for the analgesics, AAP and Nubaine, were 6.6 vs. 0.6 times and 1.7 vs. 0.9 times, in group C and P, respectively, so were significantly fewer in the P group (P<0.01). There were 5 recurrences (3.9%) in the C group during the follow up period (2~6 years), but there were none in the P group during the follow up period (5 months~2 years). The complications were similar in both groups. CONCLUSION: Compared with conventional surgical techniques, including the Lichtenstein tension free method, the PerFix(R) plug method is the most simple, and shows superiority in the following areas; the operation time, length of hospital stay, times of analgesics use and recurrence. However, with regard to the recurrence, longer follow up and observation periods are required.
Analgesics ; Follow-Up Studies ; Hernia ; Hernia, Inguinal ; Herniorrhaphy* ; Length of Stay ; Nalbuphine ; Pain Measurement ; Polypropylenes ; Recurrence

BACKGROUND: Patient-controlled analgesia (PCA) is widely used for postoperative pain control. Theoretical advantages in maintaining an effective blood concentration of the analgesic medication using a basal infusion regimen is controversal. Therefore in this study, we compared the analgesic effect between PCA and PCA with a basal infusion and assessed whether the use of a basal infusion improves the analgesic effect in intravenous PCA or not. METHODS: Twenty six ASA physical status 1 or 2 female patients undergoing mastectomy were assigned randomly to the PCA group (group 1) or the PCA with basal infusion group (group 2). Group 1 was programmed to deliver 0.02 ml/Kg of bolus infusion with a 5 minute locKout interval. In group 2, 0.02 ml/Kg of basal infusion was added to the PCA regimen. The PCA analgesic solution contained 50 mg of nalbuphine and 150 mg of Ketorolac in a total volume of 200 ml. At sKin closure, 0.2 ml/Kg of a loading dose was given to all patients and a PCA was started according to the experimental group. A visual analogue scale (VAS) for pain, analgesic consumption, side effects and degree of satisfaction was assessed at postoperative 1 hour, 2 hours, 4 hours, 8 hours, 24 hours and 48 hours. RESULTS: Group 2 did not show any improvement in the VAS compared with group 1. Degree of satisfaction and incidence of complications were not different between two groups. Total infused amount of analgesics increased in group 2 (P < 0.05). CONCLUSIONS: The addition of basal infusion in a PCA after mastectomy did not show any improvement of postoperative pain control compared to the regimen of a PCA with only bolus infusion.
Analgesia, Patient-Controlled* ; Analgesics ; Female ; Humans ; Incidence ; Ketorolac ; Mastectomy* ; Nalbuphine ; Pain, Postoperative ; Passive Cutaneous Anaphylaxis ; Skin

Nalbuphine hydrochloride is a new analgesic structurally related to naloxone, a widely used narotic antagonist, and oxymorphone, a potent narcotic analgesic. Multiple clinical trials have verified the efficacy of nalbuphine in the relief of moderate to severe pain. In general, nalbuphine appears equal to morphine in both medical and surgical use at the same dosage levels and route of administration, although nalbuphine has a slightly longer duration of action. The purpose of this study was to assess the efficacy and side effects of nalbuphine in preoperative medication. Morphine and normal saline as placebo were included for comparison purpose. Eighty four patients who were scheduled to have an elective operation were included in this randomized, double-blind study. The patients received 0.17mg/kg of nalbuphine, 0.12mg/kg of morphine or 1 ml of normal saline respectively. by intramuscular injection one hour before arriving at operation room. Sedation, level of anxiety, emesis, subjective rating on the effect of premedication and side effects were evaluated. The results were as follows: 1) The sedation score was significantly lower in nalbuphine group than placebo group. 2) The level of anxiety was significantly lower in nalbuphine and morphine group than placebo group. 3) The frequency of emesis was not significantly different among three groups. 4) In the subjective rating on the effect of premedication, nalbuphine group was significantly more favorable than placbo group. 5) The side effects such as headache and dizziness were observed, and there were no significant differences in the frequency among three groups. The results indicate that nalbuphine may be recommended as an dffective premedication agent in those situation where opiods are considered as premedication agents.
Anxiety ; Dizziness ; Double-Blind Method ; Headache ; Humans ; Injections, Intramuscular ; Morphine* ; Nalbuphine* ; Naloxone ; Oxymorphone ; Premedication* ; Vomiting

A number of recent reports have described the usefulness of the epidural injection of narcotics for the relief of postoperative pain. But the epidural use of narcotic agonist-antagonist, nalbuphine hydrochloride, has not been reported. To study the effect of epidural nalbuphine hydrochloride for postoperative pain relief, we divided 73 patients into 5 groups randomly: 3 mg nalbuphine hydrochloride in 10 ml saline (group 1, n=9); 4 mg nalbuphine hydrochloride in 10 ml saline (group 2, n=14); 5 mg nalbuphine hydrochloride in 10 ml saline (group 3, n=21); 3 mg morphine in 10 ml saline (group 4, n=16); 4 mg morphine in 10 ml saline (group 5, n=13). The results were as follows 1) The onset time of analgesic effect were average 15~20 minitues in all groups 2) The durations of analgesia of epidural nalbuphine groups were (average; 5~7 hours) significantly shorter than morphine groups (average; 31~32 hours). 3) The degree of analgesia were same between 5 groups 4) The complications were nausea, vomiting and pruritus in all groups, but the frequency of pruritus in morphine groups was more than nalbuphine groups (p<0.05). 5) Urinary retention was observed only in morphine groups. In conclusion, the result of our study suggests that nalbuphine hydrochloride be better agent than morphine in terms of complication for postoperative pain relief but the duration of action is shorter than morphine, when injected epidurally.
Analgesia ; Humans ; Injections, Epidural ; Morphine ; Nalbuphine* ; Narcotics ; Nausea ; Pain, Postoperative* ; Pruritus ; Urinary Retention ; Vomiting

BACKGROUND: This study was undertaken to reduce the side effects of epidural morphine through the addition of nalbuphine in 37 cesarean delivery. METHODS: Forty patients were divided into 2 groups; M(control) group: bolus administration of morphine 2 mg in 0.5% bupivacaine and continuous epidural 41 hour-infusion of morphine 7mg, N(experimental) group: bolus administration of morphine 2 mg in 0.5% bupivacaine combined with nalbuphine 10mg and continuous epidural 41 hour-infusion of morphine 7mg combined with nalbuphine 10mg via the Paragon infusor. RESULTS: During the postoperative 48 hours, their pain scores and side effects were recorded at 6, 12, 18, 24, 30, 36, 42 and 48 hours. The analgesic effects were good in two groups(mean VAS <3.0) and pain scores were statistically significant at 18 and 30 hour. The incidence of pruritus, nausea, vomiting and urinary retention was decreased in group N(p<0.05). CONCLUSIONS: We concluded that continuous epidural morphine combined with nalbuphine was one of recommendable methods to reduce side effects of morphine.
Bupivacaine ; Cesarean Section* ; Female ; Humans ; Incidence ; Infusion Pumps ; Morphine* ; Nalbuphine* ; Nausea ; Pregnancy ; Pruritus ; Urinary Retention ; Vomiting

Cardiovascualar effects of a verapamil infusion were investigated in six dogs given nalbuphine-nitrous anesthesia. Verapamil 0.2 mg/kg was given followed by an infusion of 3 and 6 mcg/kg per minute. Verapamil significantly reduced the systemic vascular resistanee index and mean arterial pressure. The decrease in afterload led to an increase in cardiac index, since was little change in myocardial contractility(LV dp/dt). Administration of calcium chloride, 20 mg/kg, did not reverse tbe hemodynamic effects of verapamil. The data indicate that in dogs verapamil be even in high concentrations, during nalbuphine-nitrous oxide anesthesia without serious adverse hemodynamic sequences.
Anesthesia* ; Animals ; Arterial Pressure ; Calcium Chloride ; Dogs ; Hemodynamics ; Nalbuphine* ; Nitrous Oxide* ; Verapamil*